Clinical Trials Browser

INDUSTRY × Interventional × Malignant Ascites × Clear all

NCT06266091 2025-07-20

Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody

Phase 2 Completed

Malignant Ascites

NCT06432296 2025-07-20

Treatment of Malignant Ascites Caused by Advanced Epithelial Solid Tumors With M701 Bispecific Antibody

Phase 3 Active not recruiting

Malignant Ascites

NCT07007988 2025-06-06

SIM0388-101

Phase 1 Recruiting

Malignant Ascites